Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Califf Clears First Senate Hurdle, But FDA Decision On Abortion Pill May Complicate Final Confirmation

Jan 14 2022

• By Sarah Karlin-Smith

Robert Califf testisified 14 Dec 2022 at the Senate HELP committee — • Source: Alamy

Related Content

Calculating Califf’s Course To Confirmation

Nov 12 2021

Opioids, Abortion, And Drug Advertising: How A Califf-Led FDA Might Address Hot Button Rx Topics

Dec 15 2021

Abortion Pill Mifepristone Will No Longer Require In-Person Pick Up, US FDA Concludes

Dec 17 2021

Making Progress On Novel OTC Switch Rulemaking Has FDA Commissioner Nominee Califf’s Attention

Jan 12 2022

Additional Topics

International United States FDA Leadership Politics Advertising, Marketing & Sales Cannabidiol CBD Commercial Compliance Consumer Coronavirus COVID-19 Drug Approval Standards Enforcement Manufacturing Regulation

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window